HeartBeam, Inc. (BEAT) Stock Analysis & Investment Frameworks
HeartBeam, Inc. (BEAT) stock analysis on Invetso. Review HeartBeam, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
HeartBeam, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Specialties
- Country: US
HeartBeam, Inc. Key Financial Metrics
- Market Cap: $23.17M
- Revenue: $N/A
- ROE: -686.78%
- ROIC: -249.58%
- Dividend Yield: N/A
About HeartBeam, Inc.
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
HeartBeam, Inc. Investment Frameworks
Invetso analyzes HeartBeam, Inc. (BEAT) across the following frameworks:
- HeartBeam, Inc. 10Y Growth Potential
- HeartBeam, Inc. Scenario Analysis
- HeartBeam, Inc. Risks & Opportunities
- HeartBeam, Inc. Economic Moat
- HeartBeam, Inc. Business Model
- HeartBeam, Inc. Management
- HeartBeam, Inc. SWOT Analysis
- HeartBeam, Inc. Porter's 5 Forces
- HeartBeam, Inc. PESTLE Analysis
- HeartBeam, Inc. ESG Analysis